16:24 EDT Kyverna Therapeutics (KYTX) files $300M mixed securities shelf
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KYTX:
- Kyverna Therapeutics reports Q4 EPS (80c), consensus (86c)
- Kyverna Therapeutics Strengthens Board With New Director Appointments
- Kyverna Therapeutics appoints Sravan Emany, Andrew Miller to board
- Kyverna Therapeutics Appoints New CTO to Drive CAR-T Manufacturing
- Kyverna Therapeutics appoints Pujols as Chief Technology Officer